Guided atrial anti-tachycardia pacing for implanted cardiac stimulation

• US 7,751,886 B1
• Filed: 07/16/2007
• Issued: 07/06/2010
• Est. Priority Date: 07/16/2007
• Status: Expired due to Fees

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Inventors: Iranitalab, Pajhand
• Primary Examiner(s): Manuel; George
• Assistant Examiner(s): Narayanaswamy; Shubatra
• Application Number:
  US11/778,415
• Time in Patent Office: 1,086 Days
• Field of Search: 607 9- 16
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3686 configured for selecting the electrode configuration on a lead A61N1/3688 takes precedence
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

An implantable stimulation device that maps the location of irritable foci causing an atrial arrhythmia is provided by certain embodiments disclosed herein. The device may, for example, collect intra-cardiac data from a plurality of electrodes spatially distributed throughout a chamber of the heart. This data may be compared with data related to the location of each electrode and the electrical properties of the heart to approximate a point of origin for the atrial arrhythmia. Further embodiments may provide methods and systems for using this information to provide more efficient treatment of the atrial arrhythmia. For example, an optimized ATP pulse train may be determined based on the location of one or more irritable foci. Such an ATP pulse train may be applied to more efficiently terminate the atrial arrhythmia.

Claims

1. An implantable cardiac stimulation device comprising:

at least one lead adapted to be implanted proximate to the atrial walls of the heart;

a plurality of electrodes coupled to the at least one lead so as to be spatially distributed with respect to the atrial walls of the heart, wherein the plurality of electrodes both sense electrical activity of the heart and also are adapted to provide therapeutic stimulation to the heart;

a controller that receives signals indicative of the electrical activity of the heart from the plurality of electrodes and selects at least one electrode for the delivery of therapeutic stimulation to the heart, wherein the controller detects the existence of a supra-ventricular tachycardia event based upon the signals received from the plurality of electrodes and in response to detecting the existence of a supra-ventricular tachycardia, sequentially senses the supra-ventricular tachycardia from at least some of the plurality of electrodes that are spaced from each other and determines an appropriate electrical stimulation therapy, and selects at least one of the plurality of electrodes to deliver at least one electrical stimulation to the heart based upon the determined appropriate electrical stimulation therapy wherein the controller uses the signals from the plurality of electrodes that are spaced from each other to map location information about the origin of the supra-ventricular tachycardia.

2. The system of claim 1, wherein the plurality of electrodes comprises a right atria tip electrode, a first right atrial ring electrode, and a second right atrial ring electrode.

3. The system of claim 1, wherein the plurality of electrodes forms a spatially distributed globe of electrodes positioned within the atrium.

4. The system of claim 3, wherein the globe of electrodes comprises a plurality of lead segments, and wherein each lead segment comprises at least one local electrode and an electrode controller that is configured to activate or deactivate the at least one local electrode.

5. The system of claim 4, wherein the electrode controller is configured to receive a high-frequency signal that induces the electrode controller to activate the at least one local electrode.

6. The system of claim 1, wherein the controller determines the existence of a supra-ventricular tachycardia event by comparing an atrial tachycardia cutoff rate with a moving average atrial rate determined by using the signals received from the plurality of electrodes.

7. The system of claim 6, wherein the atrial tachycardia cutoff rate is approximately 170 beats per minute.

8. The system of claim 1, further comprising a multiplexing device that, upon the controller determining the existence of a non-ventricular tachycardia event, sequentially senses the supra-ventricular tachycardia event from the plurality of electrodes.

9. The system of claim 1, wherein the controller determines the location information of the source of the supra-ventricular tachycardia event by evaluating at least in part the relative timing of the signals received at each of the plurality of electrodes.

10. The system of claim 1, wherein the controller, upon determining the location information of the supra-ventricular tachycardia, uses the location information to select an electrode pair to provide therapeutic stimulation to attempt to inhibit the supra-ventricular tachycardia.

11. The system of claim 10, wherein the controller determines the location information of the source of the non-ventricular tachycardia event by comparing the relative timing of the signals received at each of the plurality of electrodes with the electrical characteristics of the heart to determine an approximate distance from each of the plurality of electrodes to the source of the non-ventricular tachycardia event and comparing these approximate distances to a known approximate location for each electrode to determine the source of the non-ventricular tachycardia event.

12. The system of claim 10, wherein the location information is stored for subsequent downloading to an external device.

13. An implantable device capable of measuring cardiac activity and providing stimulation to a patient'"'"'s heart, comprising:

a processor;

a memory;

a housing in which the processor and the memory are mounted wherein the housing is configured to be implanted into a patient'"'"'s body;

a plurality of electrodes located external to the housing, wherein each electrode is adapted to transmit a signal indicative of an intrinsic electrical signal originating in the heart to the processor and each electrode is adapted to provide an electrical stimulation to the heart; and

wherein the processor sequentially samples at least some of the plurality of electrodes in response to detecting the signal indicative of the intrinsic electrical signal and is capable of mapping location information about a source of the intrinsic electrical signal within the heart based upon a plurality of signals received by the processor from the sampled plurality of electrodes corresponding to the intrinsic electrical signal and storing a first set of data representing the location information about the source of the intrinsic electrical signal in the memory, wherein the processor is adapted to determine an appropriate electrical stimulation therapy based at least in part upon the location information about the source of the intrinsic electrical signal, and the processor is further adapted to induce at least one of the plurality of electrodes to deliver at least one electrical stimulation to the heart based upon the determined appropriate electrical stimulation therapy.

14. The system of claim 13, further comprising a telemetry device located in the housing and connected to the processor, wherein the telemetry device is adapted to transmit data to an external device, wherein the data is indicative of the first set of data representing the location information of the source of the intrinsic electrical signal.

15. The system of claim 13, wherein the determined electrical stimulation therapy comprises therapy that will be provided by at least one electrode determined to be relatively near the source of the intrinsic electrical signal.

16. The system of claim 13, wherein the plurality of electrodes comprise a right atrial tip electrode, a first right atrial ring electrode, and a second right atrial ring electrode.

17. The system of claim 13, wherein the processor is configured to deliver at least one electrical stimulation to the heart when the intrinsic electrical signal is determined by the processor to be indicative of an atrial tachycardia event.

18. The system of claim 13, wherein the plurality of electrodes form a spatially distributed globe of electrodes.

19. The system of claim 18, wherein the globe of electrodes comprises a plurality of lead segments, and each lead segment comprises at least one local electrode and an electrode controller configured to activate or deactivate the at least one local electrode.

20. The system of claim 19, wherein the processor is configured to generate a control signal that induces the electrode controller of one of the plurality of lead segments to activate one of the corresponding local electrodes.

21. The system of claim 13, further comprising a multiplexing device that sequentially senses the first electrical stimulation from the plurality of electrodes.

22. The system of claim 21, wherein the multiplexing device receives a high frequency signal that induces the multiplexing device to sense the first electrical stimulation from a plurality of different electrode pairs.

23. The system of claim 22, wherein the multiplexing device samples first electrical stimulation originating in the heart at each electrode pair at approximately 100 microsecond intervals.

24. The system of claim 13, wherein the processor determines the location information about the source of the intrinsic electrical signal originating in the heart by comparing the relative timing of the signals indicative of the first electrical stimulation transmitted to the processor by each of the electrodes.

25. The system of claim 24, wherein the processor determines the location information about the source of the intrinsic electrical signal originating in the heart by comparing the relative timing of the signals indicative of the first electrical stimulation transmitted to the processor by each of the electrodes with the electrical characteristics of the heart to determine an approximate distance from each of the plurality of electrodes to the source of the intrinsic electrical signal and comparing these approximate distances to a known approximate location for each electrode to determine source information about the intrinsic electrical signal.

26. A method for approximating an origin of an electrical signal generated in a heart utilizing an implanted device including a plurality of electrodes spatially distributed in a chamber of the atria, comprising:

determining whether the intrinsic electrical signal indicative of an atrial tachycardia has been detected by the plurality of spatially distributed electrodes;

in response to determining that an electrical signal indicative of an atrial tachycardia has occurred, sequentially sampling at least some of the spatially distributed plurality of electrodes to obtain information about the intrinsic electrical signal indicative of an atrial tachycardia by selectively activating electrodes for discrete time periods following the detection of an event;

storing timing information about when the intrinsic electrical signal was detected by the at least some of the plurality of spatially distributed electrodes when it is determined that the intrinsic electrical signal has been detected;

using the timing information about when the intrinsic electrical signal indicative of an atrial tachycardia was detected by each of the at least some of the plurality of electrodes in conjunction with location information of each of the plurality of electrodes to map the origin of the intrinsic electrical signal indicative of the atrial tachycardia.

27. The method of claim 26, wherein the plurality of electrodes comprise a right atrial tip electrode, a first right atrial ring electrode, and a second right atrial ring electrode.

28. The method of claim 26, wherein the plurality of electrodes form a spatially distributed globe of electrodes, and wherein the globe is formed from a plurality of rings and each ring contains at least one of the plurality of electrodes.

29. The method of claim 26, further comprising the step of determining a vector associated with an approximate direction of propagation of the intrinsic electrical signal indicative of the atrial tachycardia through the heart.

30. The method of claim 29, wherein the step of determining a vector utilizes the timing information about when the intrinsic electrical signal indicative of the atrial tachycardia was detected by each of the plurality of electrodes and a second set of data corresponding to a magnitude of the electrical signal that was detected by each of the plurality of electrodes.

31. The method of claim 30, wherein the step of comparing timing information about when the intrinsic electrical signal was detected by each of the plurality of electrodes with a known physical location of each of the plurality of electrodes to approximate the origin of the intrinsic electrical signal further comprises comparing the vector with the timing information and location information of each of the plurality of electrodes to approximate the origin of the intrinsic electrical signal.

32. The method of claim 26, further comprising the step of determining an appropriate electrical stimulation therapy based upon the origin of the intrinsic electrical signal indicative of the atrial tachycardia.

33. The method of claim 32, further comprising the step of delivering the appropriate electrical stimulation therapy when it is determined that the intrinsic electrical signal represents an atrial arrhythmia condition.

34. The method of claim 33, wherein the therapeutic electrical stimulation is an anti-tachycardia pacing pulse train that originates at a selected electrode selected as a result of the selected electrode'"'"'s relative proximity to the location of the source of the intrinsic electrical signal indicative of atrial tachycardia.